JC Scott (00:08): Welcome to the Pharmacy Benefit, a podcast where we talk about issues impacting patients, consumers, and affordable access to prescription drugs and better healthcare through the work being done by pharmacy benefit managers or PBMs. I’m
(Washington, D.C.) — The Pharmaceutical Care Management Association (PCMA) today released the following statement on the “Anticompetitive Conduct by Pharmaceutical Companies Impeding Generic or Biosimilar Competition” listening session, held jointly by the Federal Trade Commission (FTC), Department of Justice (DOJ),
Today, Thursday March 9, The Hill is hosting an important conversation titled: “Prescription for Change: Improving Competition to Lower Drug Prices,” featuring: David Schweikert (R-AZ), Member, Ways & Means Committee Tina Smith (D-MN), Member, Senate HELP Committee Lauren Aronson, Executive
Our collective will and intellects are being called upon to manage COVID-19, save lives, and restore our economy. During this public health emergency, it is crucial that every sector of our health care system step up to the challenge. And
This practice, the HHS inspector general said, could harm patients, the government and taxpayers because people might take pricey drugs instead of cheaper ones.
The Independent Pharmacy Marketplace Is Stable Over the last ten years, the number of independent retail pharmacies nationwide increased by 1,719 stores, or 8%. Over the last five years, the marketplace for independent pharmacies has experienced small fluctuations from year-to-year,
Main Information On Tadalafil Principle of Action Tadalafil is the main active ingredient of Cialis, one of the most popular drugs for erectile dysfunction (ED) today. This substance is responsible for the effect of Cialis on the male body. How
Pharmacy Benefit Companies Negotiate with Big Drug Companies to Lower Prescription Drug Costs for Patients and Families Last week, the U.S. Senate Health, Education, Labor and Pensions (HELP) Committee held a hearing, “The Need to Make Insulin Affordable for All Americans,”
(Washington, D.C.) – Today, the Pharmaceutical Care Management Association (PCMA), the national association representing pharmacy benefit managers (PBMs), fought to protect access to affordable, quality prescription drug coverage in front of the United States Supreme Court in oral arguments for Rutledge
(Washington, D.C.) — Pharmaceutical Care Management Association (PCMA) President and CEO JC Scott issued the following statement on the Administration’s announcement on 2021 Medicare Part D premiums. “PCMA applauds the Administration for its work continuing the success of the Part D
©2024 PCMA. All Rights Reserved.
